Good catch, ‘go seek’. As you previously noted (#msg-13734346), data from the phase-2b trial in treatment-refractory patients are apparently being kept under warps and will not be reported at AASLD.
I will edit the calendar file accordingly.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”